Steven Kelly

Insider Reports History

Location
New York, NY
Signature
/s/ Gregory D. Gorgas, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven Kelly:

Company Role Class Num Shares Value Price $ Report Date Ownership
Carisma Therapeutics Inc. President and CEO, Director Stock Option (Right to Buy) 500,000 28 Jan 2025 Direct
ARTELO BIOSCIENCES, INC. Director Stock Options (right to buy) 292 30 Jan 2026 Direct

Insider Reports Filed by Steven Kelly

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARTL ARTELO BIOSCIENCES, INC. 30 Jan 2026 1 $0 4 Director 02 Feb 2026, 16:48
CARM Carisma Therapeutics Inc. 28 Jan 2025 1 $0 4 President and CEO, Director 30 Jan 2025, 16:01
ARTL ARTELO BIOSCIENCES, INC. 20 Dec 2024 1 $0 4 Director 23 Dec 2024, 16:01
CARM Carisma Therapeutics Inc. 17 Jun 2024 1 $0 4 President and CEO, Director 18 Jun 2024, 19:05
ARTL ARTELO BIOSCIENCES, INC. 28 Feb 2024 12 $0 4 Director 01 Mar 2024, 20:05
CARM Carisma Therapeutics Inc. 31 Jan 2024 1 $0 4 President and CEO, Director 02 Feb 2024, 16:52
ARTL ARTELO BIOSCIENCES, INC. 04 Aug 2023 1 $0 4 Director 08 Aug 2023, 16:55
ARTL ARTELO BIOSCIENCES, INC. 30 Jun 2023 1 $0 4 Director 03 Jul 2023, 14:07
CARM Carisma Therapeutics Inc. 06 Jun 2023 1 $0 4 President and CEO, Director 08 Jun 2023, 18:20
CARM Carisma Therapeutics Inc. 07 Mar 2023 2 $0 4 President and CEO, Director 09 Mar 2023, 20:32
CARM Carisma Therapeutics Inc. 07 Mar 2023 0 $0 3 President and CEO, Director 09 Mar 2023, 20:19
ARTL ARTELO BIOSCIENCES, INC. 24 Jun 2022 1 $0 4 Director 27 Jun 2022, 17:18
ARTL ARTELO BIOSCIENCES, INC. 16 Jul 2021 1 $0 4 Director 26 Jul 2021, 16:23